We are live on ! Find out more
TTOO

T2 Biosystems, Inc

Delisted

TTOO was delisted on the 11th of February, 2025.

28 hedge funds and large institutions have $451K invested in T2 Biosystems, Inc in 2023 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 3

0% more funds holding

Funds holding: 2828 (0)

0% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 7

0% more call options, than puts

Call options by funds: $1K | Put options by funds: $1K

71% less capital invested

Capital invested by funds: $1.55M → $451K (-$1.1M)

Holders
28
Holders Change
Holders Change %
0%
% of All Funds
0.44%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
6
Reduced
3
Closed
7
Calls
$1K
Puts
$1K
Net Calls
Net Calls Change
-$18K

TTOO Hedge Fund Activity: Q2 2023 in Review

28 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q2 2023, worth a combined $451K — down 71% from $1.55M a quarter earlier.

Fund positioning in TTOO was balanced in Q2 2023: 7 funds opened new positions, 7 closed out, 6 added to existing stakes and 3 trimmed.

The largest buyer was GSA Capital Partners, adding an estimated $909K. The largest seller was Hudson Bay Capital Management, exiting entirely with an estimated $300K sold.

  • 28 institutional investors held T2 Biosystems, Inc (TTOO) as of Q2 2023, unchanged from Q1 2023.
  • Funds reported $451K of T2 Biosystems, Inc stock for Q2 2023, down 71% quarter-over-quarter.
  • 7 funds opened new T2 Biosystems, Inc positions in Q2 2023 and 7 closed out, a net change of 0 holders.
  • The largest T2 Biosystems, Inc buyer in Q2 2023 was GSA Capital Partners, an estimated $909K added.
  • The largest T2 Biosystems, Inc seller in Q2 2023 was Hudson Bay Capital Management, an estimated $300K sold.

Based on aggregated 13F filings for Q2 2023.